Old Web
English
Sign In
Acemap
>
authorDetail
>
David M. Gill
David M. Gill
University of Utah
Medicine
Pathology
Mutation
Internal medicine
Hepatobiliary Tumors
2
Papers
1
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Survival outcomes according to the tumor mutation burden and PD-L1 expression in hepatobiliary tumors.
2020
Journal of Clinical Oncology
Jorge Sánchez-García
Fidel Lopez-Verdugo
Andrew Gagnon
Diane Alonso
Shiro Fujita
Manuel Rodriguez-Davalos
Mark A. Lewis
David M. Gill
Richard Gilroy
Derrick S. Haslem
Timothy J. Yeatman
Jake Krong
Li Dong
Sean Dow
Ivan R Zendejas-Ruiz
Ramya Thota
Show All
Source
Cite
Save
Citations (1)
Efficacy of eplerenone (Epe) in the management of mineralocorticoid excess (MCE) in men with metastatic castration-resistant prostate cancer (mCRPC) treated with abiraterone (AA) without prednisone (P).
2017
Journal of Clinical Oncology
David M. Gill
David Gaston
Andrew W. Hahn
Erin B. Bailey
Tyler Howard Buckley
Eric L. Johnson
Julia A. Batten
Anitha Alex
Kenneth M. Boucher
David D. Stenehjem
Neeraj Agarwal
Show All
Source
Cite
Save
Citations (0)
1